Below are the earnings highlights for Rigel Pharmaceuticals Inc. (RIGL):
Earnings: $12.42 million in Q3 vs. -$5.69 million in the same period last year.
EPS: $0.70 in Q3 vs. -$0.33 in the same period last year.
Revenue: $55.31 million in Q3 vs. $28.13 million in the same period last year.
For comments and feedback: editorial@rttnews.com